Company page
Immix Biopharma, Inc.
Immix Biopharma, Inc. is a public company traded under the ticker IMMX in the American market. The company has a market capitalization of approximately $620.8 million. Immix Biopharma focuses on developing innovative therapies for cancer and other serious diseases.
- Ticker
- IMMX:NASDAQ
- Asset type
- Stock
- Market cap
- $620.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD